Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Conditional regional recurrence risk: The effect of event-free years in different subtypes of breast cancer.
Vane MLG, Moossdorff M, van Maaren MC, van Kuijk SMJ, van Nijnatten TJA, van Roozendaal LM, Boerma EG, de WIlt JHW, Smidt ML. Vane MLG, et al. Among authors: van roozendaal lm, van nijnatten tja, van maaren mc, van kuijk smj. Eur J Surg Oncol. 2021 Jun;47(6):1292-1298. doi: 10.1016/j.ejso.2020.11.122. Epub 2020 Nov 27. Eur J Surg Oncol. 2021. PMID: 33349525
The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patients.
van Roozendaal LM, Schipper RJ, Van de Vijver KK, Haekens CM, Lobbes MB, Tjan-Heijnen VC, de Boer M, Smidt ML. van Roozendaal LM, et al. Among authors: van de vijver kk. Breast Cancer Res Treat. 2014 Feb;143(3):469-76. doi: 10.1007/s10549-013-2822-5. Epub 2014 Jan 4. Breast Cancer Res Treat. 2014. PMID: 24390150 Clinical Trial.
Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research.
Moossdorff M, van Roozendaal LM, Strobbe LJ, Aebi S, Cameron DA, Dixon JM, Giuliano AE, Haffty BG, Hickey BE, Hudis CA, Klimberg VS, Koczwara B, Kühn T, Lippman ME, Lucci A, Piccart M, Smith BD, Tjan-Heijnen VC, van de Velde CJ, Van Zee KJ, Vermorken JB, Viale G, Voogd AC, Wapnir IL, White JR, Smidt ML. Moossdorff M, et al. Among authors: van roozendaal lm, van de velde cj, van zee kj. J Natl Cancer Inst. 2014 Nov 7;106(12):dju288. doi: 10.1093/jnci/dju288. Print 2014 Dec. J Natl Cancer Inst. 2014. PMID: 25381395 Free PMC article.
The value of completion axillary treatment in sentinel node positive breast cancer patients undergoing a mastectomy: a Dutch randomized controlled multicentre trial (BOOG 2013-07).
van Roozendaal LM, de Wilt JH, van Dalen T, van der Hage JA, Strobbe LJ, Boersma LJ, Linn SC, Lobbes MB, Poortmans PM, Tjan-Heijnen VC, Van de Vijver KK, de Vries J, Westenberg AH, Kessels AG, Smidt ML. van Roozendaal LM, et al. Among authors: van der hage ja, van de vijver kk, van dalen t. BMC Cancer. 2015 Sep 3;15:610. doi: 10.1186/s12885-015-1613-2. BMC Cancer. 2015. PMID: 26335105 Free PMC article. Clinical Trial.
34 results